The COVID-19 pandemic has challenged global responses and resources. Yet U.S. arms sales continue, including to governments with repressive regimes and considerable human rights concerns. In April 2020 alone, the Trump administration notified Congress of more than $2 billion in potential weapons exports. With COVID-19 prompting the United States and international arms purchasers to reassess their own military expenditures, the current environment may present an opportunity to rethink the United States’ approach to global arms sales. Join a discussion on the ways the administration and Congress can revise approaches to the U.S. arms trade of the future.